Single antiplatelet therapy (SAPT)

DRUG3 trials

Sponsors

Fondazione Ricerca e Innovazione Cardiovascolare ETS, Fundación EPIC, Gan Lijun

Conditions

Acute Coronary SyndromeAntineoplastic AgentsArterial Occlusive DiseasesAspirinAtherosclerosisAtrial FibrillationCardiovascular DiseasesClopidogrel

Unknown Phase

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

RecruitingNCT06535568

Fondazione Ricerca e Innovazione Cardiovascolare ETSAcute Coronary Syndrome, Antineoplastic Agents, Arterial Occlusive Diseases +22

Start: 2026-01-10End: 2028-02-20Target: 576Updated: 2026-01-22

Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry

RecruitingNCT06620757

Fundación EPICAtrial Fibrillation

Start: 2024-10-10End: 2027-10-01Target: 234Updated: 2025-07-04

Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

RecruitingNCT07587099

Gan LijunCoronary Heart Disease (CHD)

Start: 2026-05-04End: 2030-12-31Target: 2170Updated: 2026-08-17